Furthermore, the overexpression of PD-L1 on breast CSCs could be due to the hyperactivation of stemness-related pathways, since Wnt inhibitors were found to downregulate PD-L1 expression on breast cancer cell lines, whereas Wnt activators had the opposite effect [201]. This evidence concerns the gene CD274 and breast cancer.